SGA
JAZZ icon

Strategic Global Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Strategic Global Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,157
Closed -$1.29M – 156
2025
Q2 		$1.29M Buy
12,157
+1,363
+13% +$148K 0.21% 96
2025
Q1 		$1.34M Sell
10,794
-548
-5% -$71.5K 0.27% 92
2024
Q4 		$1.4M Sell
11,342
-5,858
-34% -$690K 0.26% 83
2024
Q3 		$1.92M Sell
17,200
-175
-1% -$19.2K 0.38% 70
2024
Q2 		$1.85M Buy
17,375
+323
+2% +$35.5K 0.39% 75
2024
Q1 		$2.05M Sell
17,052
-437
-2% -$53.5K 0.44% 75
2023
Q4 		$2.15M Sell
17,489
-12,056
-41% -$1.5M 0.49% 70
2023
Q3 		$3.82M Buy
+29,545
New +$3.94M 0.64% 61
2021
Q2 		– Sell
-36,466
Closed -$5.99M – 165
2021
Q1 		$5.99M Sell
36,466
-515
-1% -$84.7K 1.08% 27
2020
Q4 		$6.1M Sell
36,981
-12,092
-25% -$1.8M 1.08% 26
2020
Q3 		$7M Buy
49,073
+3,871
+9% +$480K 1.32% 18
2020
Q2 		$4.99M Buy
45,202
+6,707
+17% +$742K 1.07% 26
2020
Q1 		$3.84M Buy
38,495
+9,071
+31% +$1.17M 0.99% 29
2019
Q4 		$4.39M Buy
29,424
+427
+1% +$58.1K 0.91% 32
2019
Q3 		$3.72M Sell
28,997
-2,472
-8% -$331K 0.84% 38
2019
Q2 		$4.49M Sell
31,469
-420
-1% -$56.4K 0.96% 30
2019
Q1 		$4.56M Buy
+31,889
New +$4.16M 0.96% 30

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Strategic Global Advisors's JAZZ Position: Q3 2025 in Review

Strategic Global Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2025, closing a stake of 12,157 shares — an estimated $1.29M sold.

Strategic Global Advisors first reported a position in JAZZ in Q1 2019 and held it in 17 quarters. The position peaked at $7M in Q3 2020. 503 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.

  • Strategic Global Advisors reported no remaining Jazz Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Strategic Global Advisors sold 12,157 Jazz Pharmaceuticals shares in Q3 2025, an estimated $1.29M.
  • Strategic Global Advisors first reported a position in Jazz Pharmaceuticals in Q1 2019 and held it in 17 quarters.
  • Strategic Global Advisors's Jazz Pharmaceuticals position peaked at $7M in Q3 2020.
  • 503 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.

Based on Strategic Global Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.